Cigna invests $100 million in AI-powered specialty pharmacy program

• The program is expected to reduce clinician documentation time by up to 50% and halve the time patients wait to receive medication after prescriptions are received
• Initially launching through Cigna's specialty pharmacy Accredo, with plans to expand capabilities to other pharmacy operations in coming years
• The initiative projects $400 million in value generation by end of 2028, part of broader health insurer trend to use AI for streamlining administrative processes and reducing costs

Cigna Launches $100M AI-Powered Specialty Pharmacy Initiative

Key Investment Details:

Cigna's health services unit, Evernorth, announced a $100 million investment through 2028 to launch "Pharmacy Forward," an AI-powered specialty pharmacy program aimed at streamlining prescription processing and enhancing customer service.

Program Rollout:

The initiative will debut through Accredo, Cigna's specialty pharmacy division. The AI technology integrates clinical data and insights to generate automated summaries, enabling clinicians to spend more time on direct patient care.

Operational Benefits:

• Expected to reduce clinician documentation time by up to 50%
• Improves prior authorization requests, cutting medication delivery time in half after Accredo receives prescriptions
• Program projected to generate approximately $400 million in value by end of 2028

Facility Expansion:

Accredo is expanding capacity, staffing, and capabilities across its nearly 40 care facilities nationwide to support the enhanced program.

Market Context:

The initiative aligns with broader healthcare industry trends, as insurers increasingly adopt artificial intelligence to streamline documentation, reduce administrative burdens, and lower operational costs. Evernorth plans to extend these AI capabilities to other pharmacy operations in coming years.

Sector: Healthcare/Health Insurance

Company: Cigna (through Evernorth and Accredo subsidiaries)

Timeline: Launch date July 1, with investment extending through 2028

This strategic investment positions Cigna to leverage AI technology for competitive advantage in the specialty pharmacy market while addressing industry-wide challenges around administrative efficiency and patient care quality.